The Seattle Times | October 1, 2021
It’s tough to find mental health care no matter where you live. But those in rural communities are worse off than most. The SPIRIT trial led by John Fortney, PhD, found that telepsychiatry in rural, federally qualified health centers was a resounding success for patients who had screened positive for bipolar disorder and/or PTSD.
Department news | September 30, 2021
Mx. Taurmini Fentress, a fourth year PhD student in Social Welfare in the School of Social Work, in partnership with HaRRT Center directors Seema Clifasefi, PhD, and Susan Collins, PhD, has secured an NIAAA Research Supplement to Promote Diversity in Health-Related Research to explore resilience in managing and negotiating adverse circumstances in communities that have experienced homelessness and alcohol use disorder.
Department news | September 30, 2021
A five-year study led by John Fortney, PhD, and Jürgen Unützer, MD, MPH, MA, published in JAMA Psychiatry found that telepsychiatry in rural, federally qualified health centers was a resounding success for patients who had screened positive for bipolar disorder and/or PTSD.
Department news | September 30, 2021
We’re excited to announce that Marco Pravetoni, PhD, will be joining our department as the inaugural holder of the Rick L. Seaver Endowed Professorship for Brain Wellness funded by the Garvey Institute for Brain Health Solutions
Department news | September 30, 2021
Read the final report for the “Engaging families of children with rare genetic disorders via a novel online platform” project led by Kaitlyn Ahlers, PhD, and Eva Kurtz-Nelson, PhD.
Drug Discovery & Development | September 7, 2021
The University of Minnesota Medical School has developed a therapeutic vaccine for opioid use disorder that is the subject of a new Phase 1 randomized placebo-controlled clinical trial. Marco Pravetoni, PhD, is leading the drug discovery research and will join the UW Medicine Garvey Institute for Brain Health Solutions in 2022.
MyNorthwest | September 14, 2021
Nathan Sackett, MD, MS, says the main goal surrounding decriminalization of psychedelic substances is to make it so that they can be used in controlled, medical settings, rather than recreationally.
Psychiatric News | September 2, 2021
A telepsychiatry-based collaborative care model (CoCM) for managing patients with posttraumatic stress disorder or bipolar disorder was as effective as telepsychiatry-enhanced referral at improving patient outcomes over one year, according to a study in JAMA Psychiatry led by John Fortney, PhD.
UW Medicine newsroom | August 10, 2021
Researchers are seeking adults ages 66-75 diagnosed with depression and attention issues to participate in a clinical study evaluating the effects of a cognitive-training program using a video-game interface. Patricia Areán, PhD, is the lead for UW.
UW Medicine newsroom | August 25, 2021
The results of a five-year study published in JAMA Psychiatry found that telepsychiatry in rural, federally qualified health centers was a resounding success for patients who had screened positive for bipolar disorder and/or PTSD.
